Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 51 entries
View as:

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

Phase: N/A Priority: Normal
NCT ID: NCT02357901 Org: User:
Start: 01/28/15 End: 04/29/16 Due: 04/29/17

SUBLOCADE Long-term Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT05860959 Org: User:
Start: 08/31/23 End: 08/31/27 Due: 08/31/28

First in Man Study of Safety, Tolerability and PK Profile of RBP-7000

Phase: N/A Priority: Normal
NCT ID: NCT02765555 Org: User:
Start: 03/31/10 End: 09/30/10 Due: 09/30/11

Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT01075971 Org: User:
Start: 09/30/05 End: 11/30/05 Due: 11/30/06

PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02687984 Org: User:
Start: 02/29/16 End: 05/31/16 Due: 05/31/17

Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05694533 Org: User:
Start: 03/16/23 End: 05/01/23 Due: 05/01/24

Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02203838 Org: User:
Start: 06/30/14 End: 09/30/16 Due: 09/30/17

Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone

Phase: N/A Priority: Normal
NCT ID: NCT03978832 Org: User:
Start: 06/28/19 End: 05/12/20 Due: 05/12/21

SUBLOCADE Rapid Initiation Study

Phase: N/A Priority: Normal
NCT ID: NCT03993392 Org: User:
Start: 08/29/19 End: 12/26/19 Due: 12/26/20

Evaluating the SUBLOCADE Treatment Exit Strategy

Phase: N/A Priority: Normal
NCT ID: NCT05878210 Org: User:
Start: 11/24/23 End: 05/09/25 Due: 05/09/26

A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT00838396 Org: User:
Start: 10/31/05 End: 08/31/06 Due: 08/31/07

Evaluation of Long-term Buprenorphine Plasma Exposure

Phase: N/A Priority: Normal
NCT ID: NCT03752528 Org: User:
Start: 02/19/19 End: 07/18/19 Due: 07/18/20

Single Ascending Dose Study of RBP-7000

Phase: N/A Priority: Normal
NCT ID: NCT02768649 Org: User:
Start: 04/30/11 End: 02/29/12 Due: 02/28/13

Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06384157 Org: User:
Start: 06/10/24 End: 09/30/25 Due: 09/30/26

Study of a Novel Subcutaneous Depot Formulation of Buprenorphine

Phase: N/A Priority: Normal
NCT ID: NCT03715634 Org: User:
Start: 09/20/17 End: 06/07/18 Due: 06/07/19

A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02511886 Org: User:
Start: 09/30/15 End: 01/31/16 Due: 01/31/17

Survey of Buprenorphine Use Among "Out of Care" Population in France (P04933)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00756353 Org: User:
Start: 06/30/06 End: 12/31/06 Due: 12/31/07

Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01846455 Org: User:
Start: 09/30/12 End: 05/31/13 Due: 05/31/14

Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00279565 Org: User:
Start: 08/31/05 End: 02/28/07 Due: 02/28/08

Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

Phase: N/A Priority: Normal
NCT ID: NCT02765867 Org: User:
Start: 11/30/10 End: 05/31/11 Due: 05/31/12

Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT00901875 Org: User:
Start: 03/31/09 End: 01/31/10 Due: 01/31/11

Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population

Phase: N/A Priority: Normal
NCT ID: NCT02038790 Org: User:
Start: 11/30/13 End: 11/30/13 Due: 11/30/14

Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00684073 Org: User:
Start: 07/31/07 End: 12/31/07 Due: 12/31/08

An Observational Study of Environmental and Socioeconomic Factors in Opioid Recovery - Long Term

Phase: N/A Priority: Normal
NCT ID: NCT04577144 Org: User:
Start: 09/20/20 End: 01/11/21 Due: 01/11/22

Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)

Phase: N/A Priority: Normal
NCT ID: NCT00723749 Org: User:
Start: 03/31/08 End: 12/31/10 Due: 12/31/11